Home » Topics » Regulatory

Regulatory
RSS

Novartis files supplemental NDA for Starlix

Jan. 3, 2003

Olux approved for treatment of psoriasis

Jan. 3, 2003

Cephalon files sNDA for Provigil

Jan. 3, 2003

Casodex 150 mg not recommended for use in U.S. in early prostate cancer

Jan. 2, 2003

E.U. approval obtained for once-weekly Actonel/Optinate for postmenopausal osteoporosis

Jan. 2, 2003

Once-daily Depakote ER approved for certain forms of epilepsy

Jan. 2, 2003

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

Shire seeks approval of Adderall XR in adults

Dec. 23, 2002

Kytril available in oral solution for CINV and RINV

Dec. 23, 2002

Moxifloxacin NDA filed for bacterial conjunctivitis and ophthalmia neonatorum

Dec. 20, 2002